5-hydroxymethylcytosine loss is associated with poor prognosis for patients with WHO grade II diffuse astrocytomas.
Zhang F, Liu Y, Zhang Z, Li J, Wan Y, Zhang L, Wang Y, Li X, Xu Y, Fu X, Zhang X, Zhang M, Zhang Z, Zhang J, Yan Q, Ye J, Wang Z, Chen CD, Lin W, Li Q.
Zhang F, et al.
Sci Rep. 2016 Feb 11;6:20882. doi: 10.1038/srep20882.
Sci Rep. 2016.
PMID: 26864347
Free PMC article.